Suppr超能文献

超滤在重度充血性心力衰竭治疗中的应用

Ultrafiltration in the treatment of severe congestive heart failure.

作者信息

Grapsa Eirini, Alexopoulos George P, Margari Zafeiria, Terrovitis John V, Kontoyannis Dimitrios A, Nanas John N

机构信息

University of Athens School of Medicine, Department of Clinical Therapeutics, Alexandra Hospital, Athens, Greece.

出版信息

Int Urol Nephrol. 2004;36(2):269-72. doi: 10.1023/b:urol.0000034633.95171.64.

Abstract

BACKGROUND

Fluid removal remains a fundamental goal in the treatment of congestive heart failure (CHF). Vacuum ultrafiltration, hemodialysis, or a combination of both was used in patients with severe CHF (NYHA class IV), severe edema, and insensitivity to pharmacological treatment with diuretics.

METHODS

The aim of the study was to remove the overload fluid in eighteen patients, 13 men and 5 women, aged 38 to 83, with a man age of 66 years with intractable congestive heart failure. All patients were hospitalized because of severe congestive heart failure and did not respond to treatment with intravenous administration of a high dose of diuretics and positive inotropic agents. They thus underwent vacuum ultrafiltration (1 to 27 sessions) while in 4 of them hemodialysis was also performed because of high serum creatinine levels (over 4 mg/dl). Subclavian catheters were used in all patients and arteriovenous fistula was later performed in 2, because of the need for long term treatment. The average fluid removed was 2 L per session and the total fluid removed ranged from 4 to 29 L.

RESULTS

Fourteen of the 18 patients (78%) showed significant improvement in their clinical status. Ten patients (56%) had a short term improvement but expired after 7 to 107 days of hospitalization. Four patients (22%) died after only one session of dialysis and 4 patients (22%) recovered after 8 to 23 dialysis sessions and were discharged from hospital.

CONCLUSION

The majority of patients with severe chronic CHF which is intractable to conventional therapy including intravenous diuretics and inotropes improve by the use of ultrafiltration. However, a limited proportion of them survive to be discharged from the hospital.

摘要

背景

液体清除仍是充血性心力衰竭(CHF)治疗的基本目标。对于重度CHF(纽约心脏协会IV级)、重度水肿且对利尿剂药物治疗不敏感的患者,采用了真空超滤、血液透析或两者联合的治疗方法。

方法

本研究的目的是清除18例患者体内过多的液体,其中男性13例,女性5例,年龄38至83岁,平均年龄66岁,患有顽固性充血性心力衰竭。所有患者均因严重充血性心力衰竭住院,对静脉注射大剂量利尿剂和正性肌力药物治疗无反应。因此,他们接受了真空超滤(1至27次),其中4例因血清肌酐水平高(超过4mg/dl)还进行了血液透析。所有患者均使用锁骨下导管,2例因需要长期治疗后来进行了动静脉内瘘手术。每次超滤平均清除液体2L,总清除液体量为4至29L。

结果

18例患者中有14例(78%)临床状况有显著改善。10例患者(56%)有短期改善,但在住院7至107天后死亡。4例患者(22%)仅进行一次透析后死亡,4例患者(22%)在进行8至23次透析后康复并出院。

结论

大多数重度慢性CHF患者,对包括静脉利尿剂和正性肌力药物在内的传统治疗方法难以奏效,但通过超滤治疗可得到改善。然而,其中仅有一小部分患者能够存活并出院。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验